References
- Simpson LE, Leung DYM, Eichenfield LF, Dan Boguniewicz M. Atopic dermatitis. In: Dalam KS, Amagai M, Bruckner AL, et al., editors. Fitzpatrick’s Dermatology in General Medicine: Dermatitis. Edisi Ke- 9. New York: McGraw-Hill; 2019:363–384.
- Simon D, Wollenberg A, Renz H, Dan simon HU. Atopic dermatitis: Collegium Internationale Allergologicum (CIA) update 2019. Int Arch Allergy Immunol. 2019;178(3):207–218. doi:10.1159/000497383
- Wisneiwski JA, Agrawal R, Minnicozzi S, et al. Sensitization to food and inhalant allergens in relation to age and wheeze among children with atopic dermatitis. Clin Exp Allergy. 2013;43(10):1160–1170. doi:10.1111/cea.12169
- Bauer Stephen M. Atopic Eczema: genetic associations and potential links to developmental exposures. Int J Toxicol. 2017;36(3):1–12.
- Al-Shobaili HA, Ahmed AA, Alnomair N, Alobead ZA, Dan Rasheed Z. Molecular genetic of atopic dermatitis: an update. Int J Health Sci. 2016;10(1):1–25. doi:10.12816/0031218
- Zaniboni MC, Orfali RL, Samorano LP, Dan Aoki V. Skin barrier in atopic dermatitis: beyond filaggrin. An Bras Dermatol. 2016;91(4):472–478. doi:10.1590/abd1806-4841.20164412
- Muluk NB, Altın F, Cingi C. Role of superantigens in allergic inflammation: their relationship to allergic rhinitis, chronic rhinosinusitis, asthma, and atopic dermatitis. Am J Rhinol Allergy. 2018;32(6):1–16.
- Koymans KJ, Goldmann O, Christofer AQ, et al. The TLR2 antagonist staphylococcal superantigen-like protein 3 acts as a virulence factor to promote bacterial pathogenicity in vivo. J Innate Immun. 2017;9:561–573. doi:10.1159/000479100
- Askarian F, Wagner T, Johannessen M, Nizet V. Staphylococcus aureus modulation of innate immune responses through Toll-like (TLR), (NOD)-like (NLR) and C-type lectin (CLR) receptors. Fems Microbiol Rev. 2018;42(5):656–671. doi:10.1093/femsre/fuy025
- Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5(461):1–8. doi:10.3389/fimmu.2014.00461
- Tokuyama M, Mabuchi T. New treatment addressing the pathogenesis of psoriasis. Int J Mol Sci. 2020;21(20):1–16. doi:10.3390/ijms21207488
- Fournier B. The function of TLR2 during staphylococcal diseases. Front Cell Infect Microbiol. 2013;2(167):1–8. doi:10.3389/fcimb.2012.00167
- Patra MC, Choi S. Recent progress in the development of Toll-like receptor (TLR) antagonis. Expert Opin Ther Pat. 2016;26(6):719–730. doi:10.1080/13543776.2016.1185415
- Heine H, Riekenberg S. Toll-like receptor recognition of lipoglycans, glycolipids and lipopeptides. Microbial Glycobiol. 2009;31:623–635.
- Yoshikawa FSY, JFd L, Sato MN, Ramos YAL, Aoki V, Orfali RL. Exploring the role of S. aureus toxin in atopic dermatitis. Toxin. 2019;321(11):1–13.
- Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship. Trends Microbiol. 2018;26(6):484–497. doi:10.1016/j.tim.2017.11.008
- Fries BC, Varshney AK, Crowe JE., Boraschi D, Rappuoli R. Bacterial Toxins—Staphylococcal enterotoxin B. Microbiol Spectr. 2013;1(2):1–21. doi:10.1128/microbiolspec.AID-0002-2012
- Liu X, Zhan Z, Li D, et al. Intracellular MHC class II molecules promote TLR-triggered innate immune response by maintaining activation of the kinase Btk. Nat Immunol. 2011;12(5):416–425. doi:10.1038/ni.2015
- Niebuhr M, Heratizadeh A, Wichmann K, Satzger I, Werfel T. Intrinsic alterations of pro-inflammatory mediators in unstimulated and tlr-2 stimulated keratinocytes from atopic dermatitis patients. Exp Dermatol. 2011;20:468–472. doi:10.1111/j.1600-0625.2011.01277.x
- Kim JE, Kim JS, Cho DH, Park HJ. Molecular mechanisms of cutaneous inflammatory disorder: atopic dermatitis. Int J Mol Sci. 2016;17:1234. doi:10.3390/ijms17081234
- Song Z, Deng X, Chen W, et al. Toll-like receptor 2 agonist Pam3CSK4 up-regulates FcepsilonRI receptor expression on monocytes from patients with severe extrinsic atopic dermatitis. J Eur Acad Dermatol Venereol. 2015;29:2169–2176. doi:10.1111/jdv.13172
- Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol. 2011;30:16–34. doi:10.3109/08830185.2010.529976
- Tsybikov NN, Petrisheva I, Fevelova EV, Kuznik BI, Dan Magen E. Expression of TLR2 and TLR4 on peripheral blood monocytes during exacerbation of atopic dermatitis. Allergy Asthma Proc. 2015;36(6):140–145. doi:10.2500/aap.2015.36.3901
- Yu Y, Zhang Y, Zhang J, et al. Impaired toll-like receptor 2-mediated Th1 and Th17/22 cytokines secretion in human peripheral blood mononuclear cells from patients with atopic dermatitis. J Trans Med. 2015;13(384):1–10. doi:10.1186/s12967-015-0744-1
- Mandron M, Aries M-F, Brehm RD, et al. Human dendritic cells conditioned with Staphylococcus aureus toxin B (SEB) promote TH-2 cell polarization. J Allergy Clin Immunol. 2006;117:1141–1147. doi:10.1016/j.jaci.2005.12.1360
- Niebuhr M, Schorling K, Heratizadeh A, Werfel T. Staphylococcal α-toxin induces a functional upregulation of TLR2 on human peripheral blood monocytes. Exp Dermatol. 2015;24:381–400. doi:10.1111/exd.12674
- Mandron M, Aries M-F, Boralevi F, et al. Age-related differences in sensitivity of peripheral blood monocytes to lipopolysaccharide and Staphylococcus aureus toxin B in atopic dermatitis. J Invest Dermatol. 2008;128:882–889. doi:10.1038/sj.jid.5701112
- Kissner TL, Ruthel G, Cisney ED, Ulrich RG, Fernandez S, Saikh KU. Myd88-dependent pro-inflammatory cytokine response contributes to lethal toxicity of staphylococcal enterotoxin b in mice. Innate Immun. 2011;17:451–462. doi:10.1177/1753425910374092
- Fassbender S, Opitz FV, Johnen S, Forster I, Weighardt H. Myd88 contributes to staphylococcal enterotoxin b-triggered atopic dermatitis-like skin inflammation in mice. J Investig Dermatol. 2017;137:1802–1804. doi:10.1016/j.jid.2017.04.015